Trial Profile
The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Patients With Diabetic Retinopathy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 03 Jan 2017 New trial record